deferoxamine has been researched along with antipyrine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bestak, M; Chang, H; Graziano, JH; Markenson, A; Meyers, P; Miller, DR; Pisciotto, P; Rifkind, A | 1 |
Futami, S; Maekawa, K; Morita, I; Murota, SI; Nishida, M | 1 |
1 trial(s) available for deferoxamine and antipyrine
Article | Year |
---|---|
Chelation therapy in beta-thalassemia major. I. Intravenous and subcutaneous deferoxamine.
Topics: Adolescent; Adult; Age Factors; Antipyrine; Child; Child, Preschool; Deferoxamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Ferritins; Humans; Infusions, Parenteral; Iron; Thalassemia | 1978 |
1 other study(ies) available for deferoxamine and antipyrine
Article | Year |
---|---|
Hypoxia-reoxygenation inhibits gap junctional communication in cultured human umbilical vein endothelial cells.
Topics: Antipyrine; Catalase; Cell Communication; Cell Hypoxia; Cells, Cultured; Deferoxamine; Dimethyl Sulfoxide; Edaravone; Endothelium, Vascular; Gap Junctions; Humans; Image Cytometry; Lasers; Oxygen; Probucol; Reactive Oxygen Species; Superoxide Dismutase; Time Factors; Umbilical Veins | 2000 |